What's breaking now, across thousands of outlets.
Hatched three years ago, the restructuring is now expected to deliver $1 billion in new cost reductions and save Pfizer another $1.5 billion by streamlining drug production.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
Gilead wins case over its HIV medicine, Eli Lilly to expand retatrutide access, and more biotech news
Iraq exported under a third of pre-war oil levels via Hormuz in July: monitor Iraq exported less than a third of its pre-war oil levels in July through the Strait of Hormuz, data from the maritime…
The bank has not accused the Trump Organization of money laundering. But Capital One said the transaction patterns it identified are “among the types of activity flagged by federal banking guidance.”
John Barstow says oil expansion is a necessity, while David Parker wonders if the prime minister will protect the planet or the fossil fuel industry North Sea oil expansion is a necessity ( Burnham…
Key sectors of the economy that spent years squeezed by high interest rates are gaining momentum. Why it matters: For years, manufacturing and construction were among the clearest signs that the…
An anonymous reader quotes a report from The Guardian: Apple has launched a new legal challenge against a UK government demand to access its customers' highly encrypted data, a year after the Home…
